-
-
-
-
-
-
-
Aviragen Therapeutics (AVIR) Misses Q3 EPS by 11c
-
-
-
-
-
-
-
Atea Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Atea Pharmaceuticals to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024
-
-
-
-
-
-
-
Aviragen Therapeutics (AVIR) Misses Q4 EPS by 4c
-
-
-
-
-
-
-
Atea Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Atea Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
-
1,197,428 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

